Although aortic valve replacement is known to mitigate bleeding risk by correcting shear stress-induced von Willebrand factor abnormalities, the patient's frailty, atrial fibrillation, and preference for conservative management complicated decision-making. This evidence concerns the gene VWF and atrial fibrillation.